Russell Frederick L. Jr.

Director Russell Frederick L. Jr. sold 4,000 shares (89.7% of holdings) of KNSL at $379.50 for $1,518,000.00

Russell Frederick L. Jr., a director of Kinsale Capital Group, executed a substantial sale of 4,000 shares at $379.50, reducing his holdings from 4.5K to 460 shares—a 89.7% reduction in stake. This transaction represents a material reduction in insider exposure to the stock, occurring at a price 4.2% below the current market price of $396.18 and 21.1% below the 52-week high of $501.97. The insider's prior trading history at this ticker is notably consistent: across 5 previous sales on 2024-11-22, all five showed negative 90-day returns ranging from -11.1% to -11.8%, with a 100% rate of being well-timed at the 90-day horizon. His cross-ticker sell history shows a 60.00% well-timed rate at 90 days with an average 90-day return of -2.0%, suggesting a demonstrated ability to time equity dispositions favorably. Given the company's strong fundamentals—$497.5M in latest quarterly revenue, net income of $141.6M, 18.0% annual revenue growth, and a reasonable P/E of 16.30—the scale of this director's position reduction warrants investor attention as a meaningful change in insider conviction.

Director Russell Frederick L. Jr. sells 4,440 shares (90.9% of holdings) at $499.31 avg for $2.2M on 2024-11-22

Russell Frederick L. Jr., a director at Kinsale Capital Group, executed 5 separate sales totaling 4,440 shares for $2,216,956.57 on 2024-11-22, reducing his position from 4,887 shares to 447 shares—a 90.9% reduction in holdings. The sales occurred at prices ranging from $496.55 to $500.76, with a blended average of $499.31, near the 52-week high of $547.98. His prior sales at KNSL show a weak 90-day timing record (1 of 5 prior sells well-timed), with the most recent 2024-03-05 sale followed by a 90-day decline of 26.6%, though his cross-ticker track record shows mixed results (avg 90d return +7.5%, 20% well-timed rate). The near-complete exit occurs during a period of strong recent momentum—the stock has appreciated 16.6% over 30 days and 3.8% over 90 days—and coincides with robust fundamentals (revenue growth +49.5% annually, P/E 28.82). The transaction leaves minimal residual exposure (447 shares remaining), suggesting a strategic liquidation of the position rather than a partial adjustment.